Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Cholangiocarcinoma 3Urinary Bladder Neoplasms 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Renal Pelvis and Ureter Urothelial Carcinoma 1Rectal Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Liver Neoplasms 1Glioma 1Glioblastoma 1Colonic Neoplasms 1Breast Neoplasms 1Advanced Gastrointestinal Stromal Tumor (GIST) 1Acrocephalosyndactylia 1

Interventions

Cisplatin 24Gemcitabine 16Radiotherapy, Intensity-Modulated 14Fluorouracil 7Radiotherapy 5Docetaxel 5pembrolizumab 4Surveys and Questionnaires 4Carboplatin 4Bevacizumab 4toripalimab 3spartalizumab 3camrelizumab 3Induction Chemotherapy 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Psychiatric Rehabilitation 2Paclitaxel 2Nivolumab 2Immunohistochemistry 2Drug Therapy 2Chemoradiotherapy 2Celecoxib 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nasopharyngeal Neoplasms × infigratinib × Clear all
NCT02706691 2019-04-16

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

University of Chicago

Phase 2 Terminated
1 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡